![Emergent BioSolutions Inc. logo](/logos/EBS.webp)
Emergent BioSolutions Inc.
NYSE:EBS
Overview | Financials
Company Name | Emergent BioSolutions Inc. |
Symbol | EBS |
Currency | USD |
Price | 7.52 |
Market Cap | 397,857,632 |
Dividend Yield | 0% |
52-week-range | 1.42 - 15.1 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Richard S. Lindahl M.B.A. |
Website | https://www.emergentbiosolutions.com |
An error occurred while fetching data.
About Emergent BioSolutions Inc.
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD